Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results.
Witzigmann
H
H
Department of Abdominal, Transplantation and Vascular Surgery, University of Leipzig, Leipzig, Germany. with@medizin.uni-leipzig.de
Rhein
T
T
Geissler
F
F
Thiery
J
J
Serr
F
F
Tannapfel
A
A
Uhlmann
D
D
Metzner
R
R
Hauss
J
J
D000328:Adult; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D010865:Pilot Projects; D011446:Prospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D002784:Cholesterol; D003404:Creatinine; D020123:Sirolimus; D016559:Tacrolimus